Publications

Publications published since 2005 or in press from OUS - Department of Oncology

894 publications found

Publications in press

1. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J
   T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
   Int J Cancer (in press)
   PubMed 21630262
2. Brandberg Y, Aamdal S, Bastholt L, Hernberg M, Stierner U, von der Maase H, Hansson J
   Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
   Eur J Cancer (in press)
   PubMed 22196968
3. Brændengen M, Tveit KM, Hjermstad MJ, Johansson H, Berglund K, Brandberg Y, Glimelius B
   Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study
   Eur J Cancer (in press)
   PubMed 21782418
4. Dahl AA, Gudbergsson SB, Dørum A, Fosså SD, Liavaag AH, Sørebø O
   "The impact of cancer scale" version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors
   Qual Life Res (in press)
   PubMed 22045155
5. de Wit R, Skoneczna I, Daugaard G, De Santis M, Garin A, Aass N, Witjes AJ, Albers P, White JD, Germa-Lluch JR, Marreaud S, Collette L
   Randomized Phase III Study Comparing Paclitaxel-Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983
   J Clin Oncol (in press)
   PubMed 22271474
6. Fosså A, Fiskvik IH, Kolstad A, Lauritzsen GF, Aurlien E, Blystad AK, Hole KH, Ikonomou IM, Holte H
   Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis
   Ann Oncol (in press)
   PubMed 21926399
7. Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG et al.
   Defining the Critical Hurdles in Cancer Immunotherapy
   J Transl Med, 9 (1), 214 (in press)
   PubMed 22168571
8. Hamre H, Kiserud CE, Ruud E, Thorsby PM, Fosså SD
   Gonadal function and parenthood 20 years after treatment for childhood lymphoma: A cross-sectional study
   Pediatr Blood Cancer (in press)
   PubMed 22021108
9. Hofsø K, Miaskowski C, Bjordal K, Cooper BA, Rustøen T
   Previous Chemotherapy Influences the Symptom Experience and Quality of Life of Women With Breast Cancer Prior to Radiation Therapy
   Cancer Nurs (in press)
   PubMed 21760482
10. Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, Bernklev T, , for the IBSEN Study Group
    Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: Results from the IBSEN study
    Inflamm Bowel Dis (in press)
    PubMed 21936030
11. Huuse EM, Moestue SA, Lindholm EM, Bathen TF, Nalwoga H, Krüger K, Bofin A, Maelandsmo GM, Akslen LA, Engebraaten O, Gribbestad IS
    In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts
    J Magn Reson Imaging (in press)
    PubMed 22170753
12. Knudsen AK, Brunelli C, Klepstad P, Aass N, Apolone G, Corli O, Montanari M, Caraceni A, Kaasa S
    Which domains should be included in a cancer pain classification system? Analyses of longitudinal data
    Pain (in press)
    PubMed 22264677
13. Knudsen AK, Aass N, Heitzer E, Klepstad P, Hjermstad MJ, Schippinger W, Brenne E, Kaasa S, Wasteson E, On behalf of the European Palliative Care Research Collaborative (EPCRC)
    Interviews with patients with advanced cancer-another step towards an international cancer pain classification system
    Support Care Cancer (in press)
    PubMed 22252546
14. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland A, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL
    Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
    Proc Natl Acad Sci U S A (in press)
    PubMed 21908711
15. Lilleby W, Tafjord G, Raabe NK
    Implementation of High-dose-rate Brachytherapy and Androgen Deprivation in Patients with Prostate Cancer
    Int J Radiat Oncol Biol Phys (in press)
    PubMed 22138456
16. Lilleby W, Willoch F, Stensvold A
    Detection of prostate cancer relapse with PET/CT using a novel radiotracer
    Acta Oncol (in press)
    PubMed 21936756
17. Lindbohm ML, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, Gunnarsdottir H
    Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study
    J Cancer Surviv (in press)
    PubMed 22042662
18. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z
    Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
    Tumour Biol (in press)
    PubMed 22252524
19. Mathiesen RR, Fjelldal R, Liestøl K, Due EU, Geigl JB, Riethdorf S, Borgen E, Rye IH, Schneider IJ, Obenauf AC, Mauermann O, Nilsen G, Christian Lingjaerde O, Børresen-Dale AL, Pantel K, Speicher MR, Naume B, Baumbusch LO
    High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer
    Int J Cancer (in press)
    PubMed 21935921
20. Naalsund Andreassen T, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O
    Is Oxycodone Efficacy Reflected in Serum Concentrations? A Multicenter, Cross-Sectional Study in 456 Adult Cancer Patients
    J Pain Symptom Manage (in press)
    PubMed 22285284
21. Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, Grimnes G, Jorde R, Simonsen GS, Furberg AS
    Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study
    Eur J Clin Microbiol Infect Dis (in press)
    PubMed 21811869
22. Olssøn I, Dahl AA
    Avoidant personality problems-their association with somatic and mental health, lifestyle, and social network. A community-based study
    Compr Psychiatry (in press)
    PubMed 22146705
23. Ringdal GI, Ringdal K, Juliebø V, Wyller TB, Hjermstad MJ, Loge JH
    Using the Mini-Mental State Examination to Screen for Delirium in Elderly Patients with Hip Fracture
    Dement Geriatr Cogn Disord, 32 (6), 394-400 (in press)
    PubMed 22301509
24. Rogne SG, Rønning P, Helseth E, Johannesen TB, Langberg CW, Lote K, Scheie D, Meling TR
    Craniotomy for brain metastases: a consecutive series of 316 patients
    Acta Neurol Scand (in press)
    PubMed 21902675
25. Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD
    Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
    BJU Int (in press)
    PubMed 21999333
26. Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S
    Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
    Prostate (in press)
    PubMed 21809351
27. Torfoss D, Høiby EA, Holte H, Kvaløy S
    The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review
    Acta Oncol (in press)
    PubMed 22175253
28. Torp S, Nielsen RA, Fosså SD, Gudbergsson SB, Dahl AA
    Change in employment status of 5-year cancer survivors
    Eur J Public Health (in press)
    PubMed 22227027
29. Torp S, Nielsen RA, Gudbergsson SB, Dahl AA
    Worksite adjustments and work ability among employed cancer survivors
    Support Care Cancer (in press)
    PubMed 22086407
30. Waldeland E, Ramberg C, Arnesen MR, Helland A, Brustugun OT, Malinen E
    Dosimetric impact of a frame-based strategy in stereotactic radiotherapy of lung tumors
    Acta Oncol (in press)
    PubMed 22304490

Publications 2012

1. Andreassen TN, Eftedal I, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2012)
   Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
   Eur J Clin Pharmacol, 68 (1), 55-64
   PubMed 21735164
2. Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S (2012)
   Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review
   Pain, 153 (2), 359-65
   PubMed 22115921
3. Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Smeland S, Fosså SD (2012)
   Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
   Br J Cancer, 106 (2), 297-306
   PubMed 22173669
4. Holmboe L, Andersen AM, Mørkrid L, Slørdal L, Hall KS (2012)
   High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
   Br J Clin Pharmacol, 73 (1), 106-14
   PubMed 21707700
5. Jóhannsdóttir IM, Hjermstad MJ, Moum T, Wesenberg F, Hjorth L, Schrøder H, Mört S, Jónmundsson G, Loge JH (2012)
   Increased prevalence of chronic fatigue among survivors of childhood cancers: A population-based study
   Pediatr Blood Cancer, 58 (3), 415-20
   PubMed 21425447
6. Nordbø A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim OM (2012)
   Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs
   Acta Anaesthesiol Scand, 56 (1), 88-94
   PubMed 22092357
7. Sagerup CM, Småstuen M, Johannesen TB, Helland A, Brustugun OT (2012)
   Increasing age and carcinoma not otherwise specified: a 20-year population study of 40,118 lung cancer patients
   J Thorac Oncol, 7 (1), 57-63
   PubMed 21900838
8. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
   Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
   Tumour Biol, 33 (1), 73-83
   PubMed 22006279
9. Sprauten M, Darrah TH, Peterson DR, Campbell ME, Hannigan RE, Cvancarova M, Beard C, Haugnes HS, Fosså SD, Oldenburg J, Travis LB (2012)
   Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer
   J Clin Oncol, 30 (3), 300-7
   PubMed 22184390
10. Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundström C, Christensson B, Sander B (2012)
    Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
    Br J Haematol, 156 (2), 225-33
    PubMed 22126847
11. Wien TN, Pike E, Wisløff T, Staff A, Smeland S, Klemp M (2012)
    Cancer risk with folic acid supplements: a systematic review and meta-analysis
    BMJ Open, 2 (1), e000653
    PubMed 22240654
12. Wist EA, Mjaaland I, Løkkevik E, Sommer HH (2012)
    Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
    J Oncol, 2012, 862921
    PubMed 22291703

Publications 2011

1. Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J (2011)
   Experimental ?-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
   EJNMMI Res, 1 (1), 18
   PubMed 22214432
2. Abouassaly R, Fossa SD, Giwercman A, Kollmannsberger C, Motzer RJ, Schmoll HJ, Sternberg CN (2011)
   Sequelae of treatment in long-term survivors of testis cancer
   Eur Urol, 60 (3), 516-26
   PubMed 21684072
3. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2011)
   Transiently redirected T cells for adoptive transfer
   Cytotherapy, 13 (5), 629-40
   PubMed 21174490
4. Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
   Palliative interventions and prognosis in patients with advanced esophageal cancer
   Dis Esophagus, 24 (7), 502-9
   PubMed 21309923
5. Andersson M, Lidbrink E, Bjerre K, Wist E, Enevoldsen K, Jensen AB, Karlsson P, Tange UB, Sørensen PG, Møller S, Bergh J, Langkjer ST (2011)
   Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study
   J Clin Oncol, 29 (3), 264-71
   PubMed 21149659
6. Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fosså SD (2011)
   Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007)
   Int J Cancer, 129 (12), 2867-74
   PubMed 21626506
7. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2011)
   Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
   Eur J Clin Pharmacol, 67 (5), 493-506
   PubMed 21140139
8. Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T (2011)
   Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005)
   Cancer Epidemiol Biomarkers Prev, 20 (8), 1770-7
   PubMed 21724855
9. Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ (2011)
   Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway
   Can J Vet Res, 75 (3), 209-15
   PubMed 22210997
10. Berg A, Brustugun OT, Lund-Iversen M, Helland Å (2011)
    Palmar bullous blistering induced by erlotinib
    J Thorac Oncol, 6 (5), 954
    PubMed 21623268
11. Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM (2011)
    Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis
    Int J Cancer, 129 (4), 780-90
    PubMed 20957651
12. Berge V, Baco E, Dahl AA, Karlsen SJ (2011)
    Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer
    Int J Urol, 18 (9), 646-51
    PubMed 21771102
13. Bergh I, Kvalem IL, Aass N, Hjermstad MJ (2011)
    What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment System
    Palliat Med, 25 (7), 716-24
    PubMed 21248179
14. Bernsdorf M, Ingvar C, Jörgensen L, Tuxen MK, Jakobsen EH, Saetersdal A, Kimper-Karl ML, Kroman N, Balslev E, Ejlertsen B (2011)
    Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
    Breast Cancer Res Treat, 126 (2), 463-70
    PubMed 21234672
15. Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK (2011)
    The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
    BMC Cancer, 11, 65
    PubMed 21310043
16. Brabrand S, Fosså SD, Cvancarova M, Lehne G (2011)
    Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals
    BJU Int, 107 (7), 1080-7
    PubMed 20825398
17. Bratland A, Dueland S, Hollywood D, Flatmark K, Ree AH (2011)
    Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
    Radiat Oncol, 6, 33
    PubMed 21473790
18. Brunsvig PF, Kyte JA, Kersten C, Sundstrøm S, Møller M, Nyakas M, Hansen GL, Gaudernack G, Aamdal S (2011)
    Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
    Clin Cancer Res, 17 (21), 6847-57
    PubMed 21918169
19. Brændengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B (2011)
    Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study
    Int J Radiat Oncol Biol Phys, 81 (4), e439-45
    PubMed 21641122
20. Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B (2011)
    Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study
    Int J Radiat Oncol Biol Phys, 81 (4), 1017-24
    PubMed 20932687
21. Cameron MG, Kersten C, van Helvoirt R, Rohde G, Fosså SD, Vistad I (2011)
    Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
    BMC Res Notes, 4, 252
    PubMed 21777440
22. Chrisanthar R, Knappskog S, Løkkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjønsberg G, Aas T, Schlichting E, Fjösne HE, Nysted A, Lillehaug JR, Lønning PE (2011)
    Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel
    PLoS One, 6 (4), e19249
    PubMed 21556366
23. Dahl AA, Nesvold IL, Reinertsen KV, Fosså SD (2011)
    Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations
    Sleep Med, 12 (6), 584-90
    PubMed 21645872
24. Dahlback HS, Brandal P, Gorunova L, Widing E, Meling TR, Krossnes BK, Heim S (2011)
    Genomic aberrations in pediatric gliomas and embryonal tumors
    Genes Chromosomes Cancer, 50 (10), 788-99
    PubMed 21717527
25. Dahlback HS, Brandal P, Krossnes BK, Fric R, Meling TR, Meza-Zepeda LA, Danielsen HE, Heim S (2011)
    Multiple chromosomal monosomies are characteristic of giant cell ependymoma
    Hum Pathol, 42 (12), 2042-6
    PubMed 21683982
26. Dahlback HS, Gorunova L, Brandal P, Scheie D, Helseth E, Meling TR, Heim S (2011)
    Genomic aberrations in diffuse low-grade gliomas
    Genes Chromosomes Cancer, 50 (6), 409-20
    PubMed 21412929
27. Dahlback HS, Gorunova L, Micci F, Scheie D, Brandal P, Meling TR, Heim S (2011)
    Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia
    Cytogenet Genome Res, 134 (2), 88-95
    PubMed 21555877
28. Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
    Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
    Curr Radiopharm, 4 (4), 321-8
    PubMed 22202154
29. Daugaard G, Skoneczna I, Aass N, De Wit R, De Santis M, Dumez H, Marreaud S, Collette L, Lluch JR, Bokemeyer C, Schmoll HJ (2011)
    A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
    Ann Oncol, 22 (5), 1054-61
    PubMed 21059637
30. Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, Connors JM, Rimsza L, Harris NL, Müller-Hermelink K, Rüdiger T, Coiffier B, Gascoyne RD, Berger F, Tobinai K, Au WY, Liang R, Montserrat E, Hochberg EP, Pileri S, Federico M, Nathwani B, Armitage JO, Weisenburger DD (2011)
    Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project
    Blood, 118 (1), 148-55
    PubMed 21566094
31. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B (2011)
    Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
    Breast Cancer Res Treat, 125 (3), 729-38
    PubMed 20449649
32. Eide MB, Lauritzsen GF, Kvalheim G, Kolstad A, Fagerli UM, Maisenhölder M, Østenstad B, Fluge Ø, Delabie J, Aarset H, Liestøl K, Holte H (2011)
    High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
    Br J Haematol, 152 (5), 600-10
    PubMed 21241276
33. Elvsåshagen T, Vera E, Bøen E, Bratlie J, Andreassen OA, Josefsen D, Malt UF, Blasco MA, Boye B (2011)
    The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder
    J Affect Disord, 135 (1-3), 43-50
    PubMed 21880373
34. Emaus A, Thune I (2011)
    Physical activity and lung cancer prevention
    Recent Results Cancer Res, 186, 101-33
    PubMed 21113762
35. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H, Navon R, Rødland E, Mäkelä R, Naume B, Perälä M, Kallioniemi O, Kristensen VN, Yakhini Z, Børresen-Dale AL (2011)
    miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
    PLoS One, 6 (2), e16915
    PubMed 21364938
36. Fangberget A, Nilsen LB, Hole KH, Holmen MM, Engebraaten O, Naume B, Smith HJ, Olsen DR, Seierstad T (2011)
    Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
    Eur Radiol, 21 (6), 1188-99
    PubMed 21127880
37. Fayers PM, Hjermstad MJ, Klepstad P, Loge JH, Caraceni A, Hanks GW, Borchgrevink P, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2011)
    The dimensionality of pain: palliative care and chronic pain patients differ in their reports of pain intensity and pain interference
    Pain, 152 (7), 1608-20
    PubMed 21458921
38. Ferrari S, Sundby Hall K, Luksch R, Tienghi A, Wiebe T, Fagioli F, Alvegard TA, Brach Del Prever A, Tamburini A, Alberghini M, Gandola L, Mercuri M, Capanna R, Mapelli S, Prete A, Carli M, Picci P, Barbieri E, Bacci G, Smeland S (2011)
    Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
    Ann Oncol, 22 (5), 1221-7
    PubMed 21059639
39. Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
    Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
    Acta Oncol, 50 (7), 1068-74
    PubMed 21745131
40. Flatmark K, Borgen E, Nesland JM, Rasmussen H, Johannessen HO, Bukholm I, Rosales R, Hårklau L, Jacobsen HJ, Sandstad B, Boye K, Fodstad Ø (2011)
    Disseminated tumour cells as a prognostic biomarker in colorectal cancer
    Br J Cancer, 104 (9), 1434-9
    PubMed 21448171
41. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
    Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
    Leuk Lymphoma, 52 (10), 2007-9
    PubMed 21663503
42. Fosså SD, Cvancarova M, Chen L, Allan AL, Oldenburg J, Peterson DR, Travis LB (2011)
    Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients
    J Clin Oncol, 29 (8), 963-70
    PubMed 21300926
43. Fosså SD, Hamre HM (2011)
    [Childhood cancer and fertility]
    Tidsskr Nor Laegeforen, 131 (15), 1412
    PubMed 21844933
44. Franco-Lie I, Iversen T, Robsahm TE, Abdelnoor M (2011)
    Incidence trends of melanoma of the skin compared with other localisations, in the Norwegian population, 1956-2005
    Ann Oncol, 22 (6), 1443-50
    PubMed 21135054
45. Førland DT, Johnson E, Saetre L, Lyberg T, Lygren I, Hetland G (2011)
    Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease
    Scand J Immunol, 73 (1), 66-75
    PubMed 21129005
46. Gjerset GM, Fosså SD, Courneya KS, Skovlund E, Jacobsen AB, Thorsen L (2011)
    Interest and preferences for exercise counselling and programming among Norwegian cancer survivors
    Eur J Cancer Care (Engl), 20 (1), 96-105
    PubMed 20345456
47. Gjerset GM, Fosså SD, Courneya KS, Skovlund E, Thorsen L (2011)
    Exercise behavior in cancer survivors and associated factors
    J Cancer Surviv, 5 (1), 35-43
    PubMed 20890674
48. Gjerset GM, Fosså SD, Dahl AA, Loge JH, Ensby T, Thorsen L (2011)
    Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients
    J Cancer Educ, 26 (4), 754-60
    PubMed 21626449
49. Graugaard PK, Rogg L, Eide H, Uhlig T, Loge JH (2011)
    Ways of providing the patient with a prognosis: a terminology of employed strategies based on qualitative data
    Patient Educ Couns, 83 (1), 80-6
    PubMed 20570463
50. Grondahl P, Ikdahl SE, Dahl AA (2011)
    Forensic psychiatric screening reports - an update
    J. Forensic Psychiatry Psychol., 22 (2), 278-282
51. Grotmol T, Bray F, Holte H, Haugen M, Kunz L, Tretli S, Aalen OO, Moger TA (2011)
    Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries
    Cancer Epidemiol Biomarkers Prev, 20 (7), 1350-7
    PubMed 21558495
52. Grov EK, Fosså SD, Dahl AA (2011)
    Insomnia in elderly cancer survivors--a population-based controlled study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health Survey of North-Trøndelag County (HUNT-2). Insomnia in elderly cancer survivors
    Support Care Cancer, 19 (9), 1319-26
    PubMed 20632038
53. Grov EK, Fosså SD, Dahl AA (2011)
    Morbidity, life style and psychosocial situation in cancer survivors aged 60-69 years: results from the Nord-Trøndelag health study (the HUNT-II study)
    BMC Cancer, 11, 34
    PubMed 21266091
54. Grov EK, Fosså SD, Dahl AA (2011)
    Short-term and long-term elderly cancer survivors: a population-based comparative and controlled study of morbidity, psychosocial situation, and lifestyle
    Eur J Oncol Nurs, 15 (3), 213-20
    PubMed 20674499
55. Gudbergsson SB, Fosså SD, Dahl AA (2011)
    Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study
    Support Care Cancer, 19 (3), 323-31
    PubMed 20135150
56. Gudbergsson SB, Torp S, Fløtten T, Fosså SD, Nielsen R, Dahl AA (2011)
    A comparative study of cancer patients with short and long sick-leave after primary treatment
    Acta Oncol, 50 (3), 381-9
    PubMed 20843177
57. Hadzidimitriou A, Agathangelidis A, Darzentas N, Murray F, Delfau-Larue MH, Pedersen LB, Lopez AN, Dagklis A, Rombout P, Beldjord K, Kolstad A, Dreyling MH, Anagnostopoulos A, Tsaftaris A, Mavragani-Tsipidou P, Rosenwald A, Ponzoni M, Groenen P, Ghia P, Sander B, Papadaki T, Campo E, Geisler C, Rosenquist R, Davi F et al. (2011)
    Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
    Blood, 118 (11), 3088-95
    PubMed 21791422
58. Hagtvedt T, Aaløkken TM, Smith HJ, Graff BA, Holte H, Kolbenstvedt A (2011)
    Enhancement characteristics of lymphomatous lymph nodes of the mediastinum
    Acta Radiol, 52 (10), 1113-8
    PubMed 22052959
59. Hamfjord J, Stangeland AM, Skrede ML, Tveit KM, Ikdahl T, Kure EH (2011)
    Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations
    Diagn Mol Pathol, 20 (3), 158-65
    PubMed 21817902
60. Hamid O, Schmidt H, Nissan A, Ridolfi L, Aamdal S, Hansson J, Guida M, Hyams DM, Gómez H, Bastholt L, Chasalow SD, Berman D (2011)
    A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
    J Transl Med, 9, 204
    PubMed 22123319
61. Hammerman PS, Sos ML, Ramos AH, Xu CX, Dutt A, Zhou WJ, Brace LE, Woods BA, Lin WC, Zhang JM, Deng XM, Lim SM, Heynck S, Peifer M, Simard JR, Lawrence MS, Onofrio RC, Salvesen HB, Seidel D, Zander T, Heuckmann JM, Soltermann A, Moch H, Koker M, Leenders F et al. (2011)
    Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
    Cancer Discov., 1 (1), 78-89
62. Hansson J, Aamdal S, Bastholt L, Brandberg Y, Hernberg M, Nilsson B, Stierner U, von der Maase H, Nordic Melanoma Cooperative Group (2011)
    Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial
    Lancet Oncol, 12 (2), 144-52
    PubMed 21256809
63. Helland Å, Skaug HM, Kleinberg L, Iversen ML, Rud AK, Fleischer T, Sagerup C, Solberg S, Jørgensen L, Ariansen S, Brustugun OT (2011)
    EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery
    J Thorac Oncol, 6 (5), 947-50
    PubMed 21623266
64. Hellbom M, Bergelt C, Bergenmar M, Gijsen B, Loge JH, Rautalahti M, Smaradottir A, Johansen C (2011)
    Cancer rehabilitation: A Nordic and European perspective
    Acta Oncol, 50 (2), 179-86
    PubMed 21231779
65. Hess SL, Jóhannsdóttir IM, Hamre H, Kiserud CE, Loge JH, Fosså SD (2011)
    Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects
    Acta Oncol, 50 (5), 653-9
    PubMed 21261507
66. Hetland G, Johnson E, Lyberg T, Kvalheim G (2011)
    The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation
    Adv Pharmacol Sci, 2011, 157015
    PubMed 21912538
67. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2011)
    Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review
    J Pain Symptom Manage, 41 (6), 1073-93
    PubMed 21621130
68. Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E (2011)
    Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
    BMC Cancer, 11, 455
    PubMed 22014070
69. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J (2011)
    Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Acta Oncol, 50 (7), 1006-14
    PubMed 21790306
70. Hurmuzlu M, Aarstad HJ, Aarstad AK, Hjermstad MJ, Viste A (2011)
    Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer
    Dis Esophagus, 24 (1), 39-47
    PubMed 20819100
71. Hysing J, Wist E (2011)
    Cardiotoxic effects of trastuzumab
    Tidsskr Nor Laegeforen, 131 (22), 2239-41
    PubMed 22085949
72. Haakensen VD, Bjøro T, Lüders T, Riis M, Bukholm IK, Kristensen VN, Troester MA, Homen MM, Ursin G, Børresen-Dale AL, Helland Å (2011)
    Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
    BMC Cancer, 11, 332
    PubMed 21812955
73. Haakensen VD, Lingjaerde OC, Lüders T, Riis M, Prat A, Troester MA, Holmen MM, Frantzen JO, Romundstad L, Navjord D, Bukholm IK, Johannesen TB, Perou CM, Ursin G, Kristensen VN, Børresen-Dale AL, Helland A (2011)
    Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
    BMC Med Genomics, 4, 77
    PubMed 22044755
74. Iversen A, Thune I, McTiernan A, Emaus A, Finstad SE, Flote V, Wilsgaard T, Lipson SF, Ellison PT, Jasienska G, Furberg AS (2011)
    Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study
    Hum Reprod, 26 (6), 1519-29
    PubMed 21467202
75. Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Jückstock J, Borgen E, Rack B, Braun S, Sommer H, Solomayer E, Pantel K, Nesland J, Friese K, Naume B (2011)
    Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis
    Clin Cancer Res, 17 (9), 2967-76
    PubMed 21415211
76. Jebsen NL, Bruland ØS, Eriksson M, Engellau J, Turesson I, Folin A, Trovik CS, Hall KS (2011)
    Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall
    Int J Radiat Oncol Biol Phys, 81 (5), 1359-66
    PubMed 20933339
77. Johansen S, Reinertsen KV, Knutstad K, Olsen DR, Fosså SD (2011)
    Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective study
    Radiat Oncol, 6, 68
    PubMed 21651829
78. Johnsen HE, Geisler C, Juvonen E, Remes K, Juliusson G, Hörnsten P, Kvaloy S, Kvalheim G, Jürgensen GW, Pedersen LM, Bergmann OJ, Schmitz A, Boegsted M (2011)
    Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment
    Bone Marrow Transplant, 46 (1), 44-51
    PubMed 20436517
79. Josefsen D, Forfang L, Dyrhaug M, Blystad AK, Stokke T, Smeland EB, Kvalheim G (2011)
    Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy
    Eur J Haematol, 87 (6), 494-502
    PubMed 21752097
80. Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB (2011)
    DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
    Mol Oncol, 5 (1), 77-92
    PubMed 21169070
81. Kjærgaard T, Cvancarova M, Steinsvåg SK (2011)
    Cigarette smoking and self-assessed upper airway health
    Eur Arch Otorhinolaryngol, 268 (2), 219-26
    PubMed 20512499
82. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S, European Palliative Care Research Collaborative (EPCRC), European Association for Palliative Care Research Network (2011)
    Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients
    Pain, 152 (5), 1139-45
    PubMed 21398039
83. Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS et al. (2011)
    The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians
    Cancer Cell, 19 (2), 273-82
    PubMed 21316605
84. Knudtsen IS, Rødal J, Brustugun OT, Helland Å, Skretting A, Malinen E (2011)
    Dynamic respiratory gated (18)FDG-PET of lung tumors - a feasibility study
    Acta Oncol, 50 (6), 889-96
    PubMed 21767189
85. Kristiansen W, Haugen TB, Witczak O, Andersen JM, Fosså SD, Aschim EL (2011)
    CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility
    Int J Androl, 34 (1), 77-83
    PubMed 20345875
86. Kurita GP, Sjogren P, Ekholm O, Kaasa S, Loge JH, Klepstad P (2011)
    Effects of Low-Dose Opioids on Cognitive Dysfunction Reply
    J. Clin. Oncol., 29 (32), 4343-4344
87. Kurita GP, Sjøgren P, Ekholm O, Kaasa S, Loge JH, Poviloniene I, Klepstad P (2011)
    Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study
    J Clin Oncol, 29 (10), 1297-303
    PubMed 21357785
88. Kyriazoglou AI, Dimitriadis E, Arnogiannaki N, Brandal P, Heim S, Pandis N (2011)
    Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas
    Cancer Genet, 204 (12), 677-81
    PubMed 22285020
89. Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011)
    Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients
    Clin Cancer Res, 17 (13), 4568-80
    PubMed 21586625
90. Landmark-Høyvik H, Dumeaux V, Reinertsen KV, Edvardsen H, Fosså SD, Børresen-Dale AL (2011)
    Blood gene expression profiling of breast cancer survivors experiencing fibrosis
    Int J Radiat Oncol Biol Phys, 79 (3), 875-83
    PubMed 21129856
91. Larssen L, Medhus AW, Hjermstad MJ, Körner H, Glomsaker T, Søberg T, Gleditsch D, Hovde O, Nesbakken A, Tholfsen JK, Skreden K, Hauge T (2011)
    Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study
    Surg Endosc, 25 (10), 3162-9
    PubMed 21487867
92. Lindbohm ML, Kuosma E, Taskila T, Hietanen P, Carlsen K, Gudbergsson S, Gunnarsdottir H (2011)
    Cancer as the cause of changes in work situation (a NOCWO study)
    Psychooncology, 20 (8), 805-12
    PubMed 20623820
93. Lægreid IK, Aasarød K, Jordhøy M (2011)
    End-stage renal disease and recruitment to randomized trials: why is it so difficult? Results from a survey among Norwegian nephrologists
    Scand J Urol Nephrol, 45 (4), 285-9
    PubMed 21492050
94. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM, Suo Z (2011)
    Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties
    PLoS One, 6 (12), e29170
    PubMed 22216200
95. Marcos NT, Bennett EP, Gomes J, Magalhaes A, Gomes C, David L, Dar I, Jeanneau C, DeFrees S, Krustrup D, Vogel LK, Kure EH, Burchell J, Taylor-Papadimitriou J, Clausen H, Mandel U, Reis CA (2011)
    ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues
    Front Biosci (Elite Ed), 3, 1443-55
    PubMed 21622148
96. Mead GM, Fossa SD, Oliver RT, Joffe JK, Huddart RA, Roberts JT, Pollock P, Gabe R, Stenning SP, MRC/EORTC seminoma trial collaborators (2011)
    Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up
    J Natl Cancer Inst, 103 (3), 241-9
    PubMed 21212385
97. Mikalsen LT, Dhakal HP, Bruland OS, Nesland JM, Olsen DR (2011)
    Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections
    Anticancer Res, 31 (12), 4053-60
    PubMed 22199261
98. Moestue SA, Engebraaten O, Gribbestad IS (2011)
    Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy
    Mol Oncol, 5 (3), 224-41
    PubMed 21536506
99. Mohty M, Duarte RF, Croockewit S, Hübel K, Kvalheim G, Russell N (2011)
    The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
    Leukemia, 25 (1), 1-6
    PubMed 21224858
100. Molloy TJ, Bosma AJ, Baumbusch LO, Synnestvedt M, Borgen E, Russnes HG, Schlichting E, van't Veer LJ, Naume B (2011)
     The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
     Breast Cancer Res, 13 (3), R61
     PubMed 21672237
101. Müller KM, Tveteraas IH, Aasrum M, Ødegård J, Dawood M, Dajani O, Christoffersen T, Sandnes DL (2011)
     Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells
     BMC Cancer, 11, 421
     PubMed 21961726
102. Negaard HF, Sandset PM, Kolset SO, Svennevig K, Østenstad B, Iversen PO (2011)
     Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
     Leuk Lymphoma, 52 (6), 1157-9
     PubMed 21463121
103. Nesvold IL, Reinertsen KV, Fosså SD, Dahl AA (2011)
     The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study
     J Cancer Surviv, 5 (1), 62-72
     PubMed 20972640
104. Oldenburg J, Lorch A, Fosså SD (2011)
     Late relapse of germ cell tumors
     Hematol Oncol Clin North Am, 25 (3), 615-26, x
     PubMed 21570613
105. Oldervoll LM, Loge JH, Lydersen S, Paltiel H, Asp MB, Nygaard UV, Oredalen E, Frantzen TL, Lesteberg I, Amundsen L, Hjermstad MJ, Haugen DF, Paulsen Ø, Kaasa S (2011)
     Physical exercise for cancer patients with advanced disease: a randomized controlled trial
     Oncologist, 16 (11), 1649-57
     PubMed 21948693
106. Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP (2011)
     Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214)
     J Clin Oncol, 29 (8), 957-62
     PubMed 21282539
107. Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
     Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
     J Clin Oncol, 29 (15), 2032-9
     PubMed 21482994
108. Olssøn I, Sørebø Ø, Dahl AA (2011)
     A cross-sectional testing of The Iowa Personality Disorder Screen in a psychiatric outpatient setting
     BMC Psychiatry, 11, 105
     PubMed 21711506
109. Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R (2011)
     Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
     J Psychosom Res, 71 (3), 136-41
     PubMed 21843747
110. Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N, MabThera International Trial (MInT) Group (2011)
     CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
     Lancet Oncol, 12 (11), 1013-22
     PubMed 21940214
111. Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H (2011)
     Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
     Brain Behav Immun, 25 (7), 1376-83
     PubMed 21496483
112. Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2011)
     DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
     Acta Oncol, 50 (1), 148-50
     PubMed 21110775
113. Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
     Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
     Mol Imaging Biol, 13 (6), 1234-40
     PubMed 21161686
114. Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W (2011)
     Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
     Clin Oncol (R Coll Radiol), 23 (5), 339-43
     PubMed 21134733
115. Rønneberg JA, Fleischer T, Solvang HK, Nordgard SH, Edvardsen H, Potapenko I, Nebdal D, Daviaud C, Gut I, Bukholm I, Naume B, Børresen-Dale AL, Tost J, Kristensen V (2011)
     Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
     Mol Oncol, 5 (1), 61-76
     PubMed 21212030
116. Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT (2011)
     Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases
     Thorax, 66 (4), 301-7
     PubMed 21199818
117. Sartor O, Bruland O (2011)
     Stromal targeted therapies in prostate and renal cancer: new concepts and knowledge
     Clin Genitourin Cancer, 9 (1), 1-2
     PubMed 21925102
118. Sartor O, Goeckeler W, Bruland O (2011)
     Stromal targeted therapy in bone metastatic prostate cancer: promise delivered
     Asian J Androl, 13 (6), 783-4
     PubMed 21857688
119. Scheie D, Meling TR, Cvancarova M, Skullerud K, Mørk S, Lote K, Eide TJ, Helseth E, Beiske K (2011)
     Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases
     Neuro Oncol, 13 (11), 1225-33
     PubMed 21856683
120. Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2011)
     A prospective study of neuropsychological functioning in testicular cancer patients
     Ann Oncol, 22 (5), 1062-70
     PubMed 21048038
121. Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2011)
     Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress
     J Psychosom Res, 70 (5), 403-10
     PubMed 21511070
122. Skaali T, Fosså SD, Andersson S, Langberg CW, Lehne G, Dahl AA (2011)
     Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?
     Psychooncology, 20 (4), 369-77
     PubMed 20878832
123. Skaali T, Fosså SD, Dahl AA (2011)
     A prospective study of cognitive complaints in patients with testicular cancer
     Clin Genitourin Cancer, 9 (1), 6-13
     PubMed 21729683
124. Smeland S, Bruland OS, Hjorth L, Brosjö O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Björk O, Alvegaard TA (2011)
     Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years
     Acta Orthop, 82 (2), 211-6
     PubMed 21434784
125. Stakkestad Ø, Larsen AC, Kvissel AK, Eikvar S, Ørstavik S, Skålhegg BS (2011)
     Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform
     BMC Biochem, 12, 7
     PubMed 21303506
126. Stensheim H, Cvancarova M, Møller B, Fosså SD (2011)
     Pregnancy after adolescent and adult cancer: a population-based matched cohort study
     Int J Cancer, 129 (5), 1225-36
     PubMed 21387311
127. Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S (2011)
     Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
     Acta Oncol, 50 (3), 408-14
     PubMed 20586661
128. Stensvold E, Magelssen H, Oskam IC (2011)
     Fertility-preserving measures for girls and young women with cancer
     Tidsskr Nor Laegeforen, 131 (15), 1429-32
     PubMed 21844944
129. Stensvold E, Magelssen H, Oskam IC (2011)
     Fertility-preserving measures for boys and young men with cancer
     Tidsskr Nor Laegeforen, 131 (15), 1433-5
     PubMed 21844945
130. Stephenson AJ, Aprikian AG, Gilligan TD, Oldenburg J, Powles T, Toner GC, Waters WB (2011)
     Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
     Urology, 78 (4 Suppl), S444-55
     PubMed 21986224
131. Strand TE, Brunsvig PF, Johannessen DC, Sundstrøm S, Wang M, Hornslien K, Bremnes RM, Stensvold A, Garpestad O, Norstein J (2011)
     Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival
     Int J Radiat Oncol Biol Phys, 80 (1), 133-41
     PubMed 20452137
132. Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
     hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
     Cancer Immunol Immunother, 60 (6), 809-18
     PubMed 21365467
133. Tamburstuen MV, Reseland JE, Spahr A, Brookes SJ, Kvalheim G, Slaby I, Snead ML, Lyngstadaas SP (2011)
     Ameloblastin expression and putative autoregulation in mesenchymal cells suggest a role in early bone formation and repair
     Bone, 48 (2), 406-13
     PubMed 20854943
134. Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G (2011)
     Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group
     J Clin Oncol, 29 (6), 719-25
     PubMed 21205748
135. Tangeraas T, Midtvedt K, Cvancarova M, Hirth A, Fredriksen PM, Tonstad S, Isaksen GA, Bjerre A (2011)
     Cardiorespiratory fitness in young adults with a history of renal transplantation in childhood
     Pediatr Nephrol, 26 (11), 2041-9
     PubMed 21541798
136. Thorsen L, Gjerset GM, Loge JH, Kiserud CE, Skovlund E, Fløtten T, Fosså SD (2011)
     Cancer patients' needs for rehabilitation services
     Acta Oncol, 50 (2), 212-22
     PubMed 21231783
137. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
     The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
     Scand J Immunol, 74 (6), 632-9
     PubMed 21883353
138. Torp S, Gudbergsson SB, Dahl AA, Fosså SD, Fløtten T (2011)
     Social support at work and work changes among cancer survivors in Norway
     Scand J Public Health, 39 (6 Suppl), 33-42
     PubMed 21382846
139. Tsai HR, Gjesdal O, Wethal T, Haugaa KH, Fosså A, Fosså SD, Edvardsen T (2011)
     Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy
     Am J Cardiol, 107 (3), 472-7
     PubMed 21257017
140. Turzer M, Brustugun OT, Waldeland E, Helland A (2011)
     Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity
     Case Rep Oncol, 4 (1), 25-34
     PubMed 21526003
141. Vistad I, Cvancarova M, Kristensen GB, Fosså SD (2011)
     A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer
     J Cancer Surviv, 5 (2), 208-16
     PubMed 21259075
142. Wahlin BE, Sundström C, Holte H, Hagberg H, Erlanson M, Nilsson-Ehle H, Lindén O, Nordström M, Ostenstad B, Geisler CH, Brown Pde N, Lehtinen T, Maisenhölder M, Tierens AM, Sander B, Christensson B, Kimby E (2011)
     T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab
     Clin Cancer Res, 17 (12), 4136-44
     PubMed 21518780
143. Warde P, Huddart R, Bolton D, Heidenreich A, Gilligan T, Fossa S (2011)
     Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
     Urology, 78 (4 Suppl), S435-43
     PubMed 21986223
144. Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, Rüdiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim WS, Holte H, Federico M, Au WY, Tobinai K, Armitage JO, Vose JM, International Peripheral T-cell Lymphoma Project (2011)
     Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
     Blood, 117 (12), 3402-8
     PubMed 21270441
145. Wiig JN, Larsen SG, Dueland S, Flatmark K, Giercksky KE (2011)
     Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome
     Colorectal Dis, 13 (5), 506-11
     PubMed 20236148
146. Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, Ekanger R, Meyer P, Kolstad A (2011)
     Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
     Blood, 118 (26), 6769-71
     PubMed 22058114
147. Zaikova O, Fosså SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldal S (2011)
     Radiotherapy or surgery for spine metastases?
     Acta Orthop, 82 (3), 365-71
     PubMed 21434789
148. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC (2011)
     Combining gene signatures improves prediction of breast cancer survival
     PLoS One, 6 (3), e17845
     PubMed 21423775
149. Zinöcker S, Wang MY, Gaustad P, Kvalheim G, Rolstad B, Vaage JT (2011)
     Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro
     PLoS One, 6 (1), e16005
     PubMed 21264307
150. Zwierzina H, Bergmann L, Fiebig H, Aamdal S, Schöffski P, Witthohn K, Lentzen H (2011)
     The preclinical and clinical activity of aviscumine: a potential anticancer drug
     Eur J Cancer, 47 (10), 1450-7
     PubMed 21482461
151. Aamdal S (2011)
     Current approaches to adjuvant therapy of melanoma
     Eur J Cancer, 47 Suppl 3, S336-7
     PubMed 21944005

Publications 2010

1. Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Karlsen KO, Sandstad B, Bjordal K (2010)
   Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital
   Acta Oncol, 49 (2), 209-18
   PubMed 19929566
2. Andersen R, Wethal T, Günther A, Fosså A, Edvardsen T, Fosså SD, Kjekshus J (2010)
   Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma
   Am J Cardiol, 105 (2), 149-52
   PubMed 20102909
3. Beiske AG, Loge JH, Hjermstad MJ, Svensson E (2010)
   Fatigue in Parkinson's disease: prevalence and associated factors
   Mov Disord, 25 (14), 2456-60
   PubMed 20976741
4. Boye K, Maelandsmo GM (2010)
   S100A4 and metastasis: a small actor playing many roles
   Am J Pathol, 176 (2), 528-35
   PubMed 20019188
5. Boye K, Nesland JM, Sandstad B, Mælandsmo GM, Flatmark K (2010)
   Nuclear S100A4 is a novel prognostic marker in colorectal cancer
   Eur J Cancer, 46 (16), 2919-25
   PubMed 20719498
6. Brandal P, Teixeira MR, Heim S (2010)
   Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?
   Genes Chromosomes Cancer, 49 (9), 763-74
   PubMed 20607708
7. Bratland A, Vetrhus T, Grøholt KK, Ree AH (2010)
   Preoperative radiotherapy in rectal signet-ring cell carcinoma - magnetic resonance imaging and treatment outcome: Report of six cases
   Acta Oncol, 49 (1), 42-9
   PubMed 20100143
8. Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA (2010)
   Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
   J Clin Oncol, 28 (9), 1573-82
   PubMed 20159821
9. Bruheim K, Guren MG, Dahl AA, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Tveit KM (2010)
   Sexual function in males after radiotherapy for rectal cancer
   Int J Radiat Oncol Biol Phys, 76 (4), 1012-7
   PubMed 19880263
10. Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit KM (2010)
    Late side effects and quality of life after radiotherapy for rectal cancer
    Int J Radiat Oncol Biol Phys, 76 (4), 1005-11
    PubMed 19540058
11. Bruheim K, Tveit KM, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Guren MG (2010)
    Sexual function in females after radiotherapy for rectal cancer
    Acta Oncol, 49 (6), 826-32
    PubMed 20615170
12. Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group III study group (2010)
    Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy
    Eur Urol, 58 (1), 134-40
    PubMed 20395037
13. Caraceni A, Zecca E, Martini C, Brunelli C, Pigni A, Gorni G, Galbiati A, Ibazeta M, Hjermstad M, Kaasa S (2010)
    The validity of average 8-h pain intensity assessment in cancer patients
    Eur J Pain, 14 (4), 441-5
    PubMed 19692275
14. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J (2010)
    Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007
    J Photochem Photobiol B, 101 (2), 174-8
    PubMed 20430639
15. Courter D, Cao H, Kwok S, Kong C, Banh A, Kuo P, Bouley DM, Vice C, Brustugun OT, Denko NC, Koong AC, Giaccia A, Le QT (2010)
    The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways
    PLoS One, 5 (3), e9633
    PubMed 20224789
16. Dahl CF, Haugnes HS, Bremnes R, Dahl O, Fosså SD, Klepp O, Wist E, Dahl AA (2010)
    A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors
    J Cancer Surviv, 4 (3), 256-65
    PubMed 20574815
17. Dahl AA (2010)
    Link between personality and cancer
    Future Oncol, 6 (5), 691-707
    PubMed 20465385
18. Dahl AA, Dahl CF (2010)
    Are there gender differences in impairment associated with high social anxiety? A community-based study
    J Anxiety Disord, 24 (5), 487-93
    PubMed 20378310
19. Dahl AA, Wiborg IM (2010)
    [Is social anxiety something to pay attention to?]
    Tidsskr Nor Laegeforen, 130 (3), 288-90
    PubMed 20160776
20. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
    CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
    Strahlenther Onkol, 186 (3), 163-8
    PubMed 20165821
21. Durowicz S, Olszewski WL, Gewartowska M, Sta?czyk M, Stanis?awska J, Wluka A (2010)
    Spleen migrating dendritic cells primed with CC531 colon cancer antigen and LPS - is it a method to compromise liver metastases?
    Surg Oncol, 19 (4), e85-94
    PubMed 19665370
22. Edvardsen H, Brunsvig PF, Solvang H, Tsalenko A, Andersen A, Syvanen AC, Yakhini Z, Børresen-Dale AL, Olsen H, Aamdal S, Kristensen VN (2010)
    SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance
    Pharmacogenomics J, 10 (6), 513-23
    PubMed 20157331
23. Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
    Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
    Blood, 116 (9), 1489-97
    PubMed 20505157
24. Emaus A, Veierød MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I (2010)
    Metabolic profile, physical activity, and mortality in breast cancer patients
    Breast Cancer Res Treat, 121 (3), 651-60
    PubMed 19882245
25. Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K (2010)
    Sexuality and fertility in women with Addison's disease
    J Clin Endocrinol Metab, 95 (9), 4354-60
    PubMed 20610594
26. Falk Dahl CA, Dahl AA (2010)
    Lifestyle and social network in individuals with high level of social phobia/anxiety symptoms: a community-based study
    Soc Psychiatry Psychiatr Epidemiol, 45 (3), 309-17
    PubMed 19468662
27. Falk Dahl CA, Reinertsen KV, Nesvold IL, Fosså SD, Dahl AA (2010)
    A study of body image in long-term breast cancer survivors
    Cancer, 116 (15), 3549-57
    PubMed 20564138
28. Folkvord S, Flatmark K, Dueland S, de Wijn R, Grøholt KK, Hole KH, Nesland JM, Ruijtenbeek R, Boender PJ, Johansen M, Giercksky KE, Ree AH (2010)
    Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling
    Int J Radiat Oncol Biol Phys, 78 (2), 555-62
    PubMed 20675069
29. Fors EA, Bertheussen GF, Thune I, Juvet LK, Elvsaas IK, Oldervoll L, Anker G, Falkmer U, Lundgren S, Leivseth G (2010)
    Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review
    Psychooncology, 20 (9), 909-918
    PubMed 20821803
30. Foss A, Adam R, Dueland S (2010)
    Liver transplantation for colorectal liver metastases: revisiting the concept
    Transpl Int, 23 (7), 679-85
    PubMed 20477993
31. Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L (2010)
    NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
    Mol Cancer, 9, 113
    PubMed 20482849
32. Geisler CH, Kolstad A, Laurell A, Räty R, Jerkeman M, Eriksson M, Nordström M, Kimby E, Boesen AM, Nilsson-Ehle H, Kuittinen O, Lauritzsen GF, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group (2010)
    The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
    Blood, 115 (8), 1530-3
    PubMed 20032504
33. Grotterød I, Maelandsmo GM, Boye K (2010)
    Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB
    BMC Cancer, 10, 241
    PubMed 20507646
34. Grov EK, Fosså SD, Dahl AA (2010)
    Activity of daily living problems in older cancer survivors: a population-based controlled study
    Health Soc Care Community, 18 (4), 396-406
    PubMed 20491969
35. Hagtvedt T, Aaløkken TM, Smith HJ, Graff BA, Holte H, Kolbenstvedt A (2010)
    Enhancement characteristics of lymphomatous lymph nodes of the neck
    Acta Radiol, 51 (5), 555-62
    PubMed 20429760
36. Haugen DF, Hjermstad MJ, Hagen N, Caraceni A, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2010)
    Assessment and classification of cancer breakthrough pain: a systematic literature review
    Pain, 149 (3), 476-82
    PubMed 20236762
37. Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD (2010)
    Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
    J Clin Oncol, 28 (30), 4649-57
    PubMed 20855830
38. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, Scheie D, Vik A, Meling TR (2010)
    Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
    Acta Neurol Scand, 122 (3), 159-67
    PubMed 20298491
39. Hogendoorn PC, ESMO/EUROBONET Working Group, Athanasou N, Bielack S, De Alava E, Dei Tos AP, Ferrari S, Gelderblom H, Grimer R, Hall KS, Hassan B, Hogendoorn PC, Jurgens H, Paulussen M, Rozeman L, Taminiau AH, Whelan J, Vanel D (2010)
    Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 21 Suppl 5, v204-13
    PubMed 20555083
40. Haakensen VD, Biong M, Lingjærde OC, Holmen MM, Frantzen JO, Chen Y, Navjord D, Romundstad L, Lüders T, Bukholm IK, Solvang HK, Kristensen VN, Ursin G, Børresen-Dale AL, Helland A (2010)
    Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
    Breast Cancer Res, 12 (4), R65
    PubMed 20799965
41. Jacobsen KD, Tausjø J, Hager B, Gundersen S (2010)
    [Treatment of metastatic malignant melanoma localized to an extremity]
    Tidsskr Nor Laegeforen, 130 (1), 21-4
    PubMed 20094118
42. Jantunen E, Kvalheim G (2010)
    Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies
    Eur J Haematol, 85 (6), 463-71
    PubMed 20738393
43. Jóhannsdóttir IM, Hjermstad MJ, Moum T, Wesenberg F, Hjorth L, Schrøder H, Lähteenmäki P, Jónmundsson G, Loge JH (2010)
    Social outcomes in young adult survivors of low incidence childhood cancers
    J Cancer Surviv, 4 (2), 110-8
    PubMed 20082150
44. Johnsen BO, Lingaas E, Torfoss D, Strøm EH, Nordøy I (2010)
    A large outbreak of Listeria monocytogenes infection with short incubation period in a tertiary care hospital
    J Infect, 61 (6), 465-70
    PubMed 20813130
45. Kiserud CE, Loge JH, Fosså A, Holte H, Cvancarova M, Fosså SD (2010)
    Mortality is persistently increased in Hodgkin's lymphoma survivors
    Eur J Cancer, 46 (9), 1632-9
    PubMed 20219350
46. Kjaergaard T, Cvancarova M, Steinsvaag SK (2010)
    Smoker's nose: structural and functional characteristics
    Laryngoscope, 120 (7), 1475-80
    PubMed 20564717
47. Kristjansson SR, Jordhoy MS, Nesbakken A, Skovlund E, Bakka A, Johannessen HO, Wyller TB (2010)
    Which elements of a comprehensive geriatric assessment (CGA) predict post-operative complications and early mortality after colorectal cancer surgery?
    J. Geriatr. Oncol., 1 (2), 57-65
48. Kristjansson SR, Nesbakken A, Jordhøy MS, Skovlund E, Audisio RA, Johannessen HO, Bakka A, Wyller TB (2010)
    Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study
    Crit Rev Oncol Hematol, 76 (3), 208-17
    PubMed 20005123
49. Kvåle R, Møller B, Angelsen A, Dahl O, Fosså SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F (2010)
    Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007
    Cancer Epidemiol, 34 (4), 359-67
    PubMed 20627840
50. Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fosså SD (2010)
    Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy
    Prostate Cancer Prostatic Dis, 13 (2), 144-50
    PubMed 20101260
51. Kyrdalen AE, Dahl AA, Hernes E, Hem E, Fosså SD (2010)
    Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs
    Prostate, 70 (13), 1480-9
    PubMed 20687221
52. König M, Mork J, Hall KS, Osnes T, Meling TR (2010)
    Multimodal treatment of osteogenic sarcoma of the jaw
    Skull Base, 20 (3), 207-12
    PubMed 21318040
53. Lagunova Z, Porojnicu AC, Grant WB, Bruland Ø, Moan JE (2010)
    Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?
    Mol Nutr Food Res, 54 (8), 1127-33
    PubMed 20512788
54. Landmark-Høyvik H, Reinertsen KV, Loge JH, Kristensen VN, Dumeaux V, Fosså SD, Børresen-Dale AL, Edvardsen H (2010)
    The genetics and epigenetics of fatigue
    PM R, 2 (5), 456-65
    PubMed 20656628
55. Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P (2010)
    Health care providers underestimate symptom intensities of cancer patients: a multicenter European study
    Health Qual Life Outcomes, 8, 104
    PubMed 20858248
56. Lerdal A, Lee KA, Rokne B, Knudsen Ø, Wahl AK, Dahl AA (2010)
    A population-based study of associations between current posttraumatic stress symptoms and current fatigue
    J Trauma Stress, 23 (5), 606-14
    PubMed 20890987
57. Linch DC, Yung L, Smith P, Maclennan K, Jack A, Hancock B, Cunningham D, Hoskin P, Qian W, Holte H, Boesen AM, Grigg A, Browett P, Trneny M (2010)
    Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL
    Br J Haematol, 149 (2), 237-43
    PubMed 20201949
58. Lu M, Grov E, Holmoy KH, Trinh NQ, Larsen TE (2010)
    Tunnel stability and in-situ rock stress
    ROCK STRESS AND EARTHQUAKES, 27-34
59. Laake I, Thune I, Selmer R, Tretli S, Slattery ML, Veierød MB (2010)
    A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon
    Cancer Epidemiol Biomarkers Prev, 19 (6), 1511-22
    PubMed 20501754
60. Mai PL, Friedlander M, Tucker K, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Bonaïti-Pellié C, Heidenreich A, Albers P, Bodrogi I, Geczi L, Olah E, Daly PA, Guilford P, Fosså SD, Heimdal K, Liubchenko L, Tjulandin SA, Stoll H, Weber W, Easton DF, Dudakia D et al. (2010)
    The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred
    Urol Oncol, 28 (5), 492-9
    PubMed 19162511
61. Marienhagen K, Helland A, Nordberg T, Guren MG, Hofsli E (2010)
    [How do Norwegian oncologists perceive their working conditions?]
    Tidsskr Nor Laegeforen, 130 (5), 487-9
    PubMed 20224615
62. Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlén J, Bergsträsser E, Fosså A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, Körholz D (2010)
    Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study
    J Clin Oncol, 28 (23), 3680-6
    PubMed 20625128
63. Moan J, Lagunova Z, Bruland O, Juzeniene A (2010)
    Seasonal variations of cancer incidence and prognosis
    Dermatoendocrinol, 2 (2), 55-7
    PubMed 21547098
64. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
    Mol. Oncol., 4 (2), 169
65. Nesvold IL, Fosså SD, Holm I, Naume B, Dahl AA (2010)
    Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life
    Acta Oncol, 49 (3), 347-53
    PubMed 19842790
66. Olssøn I, Sørebø Ø, Dahl AA (2010)
    The Norwegian version of the Experiences in Close Relationships measure of adult attachment: psychometric properties and normative data
    Nord J Psychiatry, 64 (5), 340-9
    PubMed 20337569
67. Ostergaard SD, Foldager L, Allgulander C, Dahl AA, Huuhtanen MT, Rasmussen I, Munk-Jørgensen P (2010)
    Psychiatric caseness is a marker of major depressive episode in general practice
    Scand J Prim Health Care, 28 (4), 211-5
    PubMed 20624110
68. Potapenko IO, Haakensen VD, Lüders T, Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC, Børresen-Dale AL (2010)
    Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression
    Mol Oncol, 4 (2), 98-118
    PubMed 20060370
69. Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM (2010)
    Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
    Pigment Cell Melanoma Res, 23 (3), 449-51
    PubMed 20236249
70. Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T (2010)
    Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
    J Immunol Methods, 355 (1-2), 52-60
    PubMed 20171968
71. Ree AH, Dueland S, Folkvord S, Hole KH, Seierstad T, Johansen M, Abrahamsen TW, Flatmark K (2010)
    Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
    Lancet Oncol, 11 (5), 459-64
    PubMed 20378407
72. Reidunsdatter RJ, Lund JA, Fransson P, Widmark A, Fosså SD, Kaasa S (2010)
    Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity
    Int J Radiat Oncol Biol Phys, 77 (3), 793-804
    PubMed 19879063
73. Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fosså SD (2010)
    Predictors and course of chronic fatigue in long-term breast cancer survivors
    J Cancer Surviv, 4 (4), 405-14
    PubMed 20862614
74. Rogg L, Aasland OG, Graugaard PK, Loge JH (2010)
    Direct communication, the unquestionable ideal? Oncologists' accounts of communication of bleak prognoses
    Psychooncology, 19 (11), 1221-8
    PubMed 20186873
75. Ruland CM, Holte HH, Røislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaløy SO, Hasund L, Ellison MC (2010)
    Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial
    J Am Med Inform Assoc, 17 (4), 403-10
    PubMed 20595307
76. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
    Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
    Sci Transl Med, 2 (38), 38ra47
    PubMed 20592421
77. Rutskij R, Gaarden T, Bremnes R, Dahl O, Finset A, Fossa SD, Klepp O, Sorebo O, Wist E, Dahl AA (2010)
    A study of coping in long-term testicular cancer survivors
    Psychol Health Med, 15 (2), 146-58
    PubMed 20391232
78. Rønning B, Wyller TB, Seljeflot I, Jordhøy MS, Skovlund E, Nesbakken A, Kristjansson SR (2010)
    Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients
    Age Ageing, 39 (6), 758-61
    PubMed 20843962
79. Sakhi AK, Bøhn SK, Smeland S, Thoresen M, Smedshaug GB, Tausjø J, Svilaas A, Karlsen A, Russnes KM, Svilaas T, Blomhoff R (2010)
    Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma
    Nutr Cancer, 62 (3), 322-8
    PubMed 20358469
80. Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH (2010)
    Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors
    Acta Radiol, 51 (3), 316-25
    PubMed 20092374
81. Stakenborg T, Liu C, Henry O, Borgen E, Laddach N, Roeser T, Ritzi-Lehnert M, Fermér C, Hauch S, O'Sullivan CK, Lagae L (2010)
    Automated genotyping of circulating tumor cells
    Expert Rev Mol Diagn, 10 (6), 723-9
    PubMed 20843197
82. Steinsvik EA, Fosså SD, Axcrona K, Fransson P, Widmark A, Dahl AA (2010)
    Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer
    J Urol, 184 (2), 525-31
    PubMed 20620412
83. Svindseth MF, Nøttestad JA, Dahl AA (2010)
    A study of outcome in patients treated at a psychiatric emergency unit
    Nord J Psychiatry, 64 (6), 363-71
    PubMed 20297944
84. Syse A, Loge JH, Lyngstad TH (2010)
    Does childhood cancer affect parental divorce rates? A population-based study
    J Clin Oncol, 28 (5), 872-7
    PubMed 20038725
85. Søreide K, Aagnes B, Møller B, Westgaard A, Bray F (2010)
    Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007
    Scand J Gastroenterol, 45 (1), 82-92
    PubMed 19883280
86. Tamburstuen MV, Reppe S, Spahr A, Sabetrasekh R, Kvalheim G, Slaby I, Syversen U, Lyngstadaas SP, Reseland JE (2010)
    Ameloblastin promotes bone growth by enhancing proliferation of progenitor cells and by stimulating immunoregulators
    Eur J Oral Sci, 118 (5), 451-9
    PubMed 20831578
87. Tauro S, Cochrane L, Lauritzsen GF, Baker L, Delabie J, Roberts C, Mahendra P, Holte H (2010)
    Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols
    Am J Hematol, 85 (4), 261-3
    PubMed 20201088
88. Tierens AM, Holte H, Warsame A, Ikonomou IM, Wang J, Chan WC, Delabie J (2010)
    Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type
    Haematologica, 95 (8), 1334-41
    PubMed 20145271
89. Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen FE, Williams JP, Nichols CR, Einhorn LH, Fossa SD (2010)
    Testicular cancer survivorship: research strategies and recommendations
    J Natl Cancer Inst, 102 (15), 1114-30
    PubMed 20585105
90. Turzer M, Brustugun OT, Helland A (2010)
    Excessive Soft Tissue Reaction after Stereotactic Body Radiation Therapy in a Woman with Four Different Cancer Diagnoses
    Case Rep Oncol, 3 (2), 195-201
    PubMed 20740196
91. Utne I, Miaskowski C, Bjordal K, Paul SM, Rustoen T (2010)
    The relationships between mood disturbances and pain, hope, and quality of life in hospitalized cancer patients with pain on regularly scheduled opioid analgesic
    J Palliat Med, 13 (3), 311-8
    PubMed 20078225
92. Van Belle V, Van Calster B, Brouckaert O, Vanden Bempt I, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, Van Huffel S, Neven P (2010)
    Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis
    J Clin Oncol, 28 (27), 4129-34
    PubMed 20713855
93. Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN (2010)
    Allele-specific copy number analysis of tumors
    Proc Natl Acad Sci U S A, 107 (39), 16910-5
    PubMed 20837533
94. van Oers MH, Tönnissen E, Van Glabbeke M, Giurgea L, Jansen JH, Klasa R, Marcus RE, Wolf M, Kimby E, Vranovsky A, Holte H, Hagenbeek A, van der Reijden BA (2010)
    BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study
    J Clin Oncol, 28 (13), 2246-52
    PubMed 20368567
95. van Oers MH, Van Glabbeke M, Giurgea L, Klasa R, Marcus RE, Wolf M, Kimby E, van t Veer M, Vranovsky A, Holte H, Hagenbeek A (2010)
    Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study
    J Clin Oncol, 28 (17), 2853-8
    PubMed 20439641
96. Weiss J, Sos ML, Seidel D, Peifer M, Zander T, Heuckmann JM, Ullrich RT, Menon R, Maier S, Soltermann A, Moch H, Wagener P, Fischer F, Heynck S, Koker M, Schöttle J, Leenders F, Gabler F, Dabow I, Querings S, Heukamp LC, Balke-Want H, Ansén S, Rauh D, Baessmann I et al. (2010)
    Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer
    Sci Transl Med, 2 (62), 62ra93
    PubMed 21160078
97. Wethal T, Haugnes HS, Kjekshus J, Småstuen MC, Ueland T, Aukrust P, Fosså SD (2010)
    C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
    Eur J Cancer, 46 (18), 3425-33
    PubMed 20832295
98. Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein M (2010)
    The role of interferons in the treatment of osteosarcoma
    Pediatr Blood Cancer, 54 (3), 350-4
    PubMed 19902521
99. Wranicz P, Herlofson BB, Evensen JF, Kongsgaard UE (2010)
    Prevention and treatment of trismus in head and neck cancer: A case report and a systematic review of the literature
    Scandinavian Journal of Pain, 1 (2), 84-88
    PublikaID 54
100. Zaikova O, Fosså SD, Kongsgaard U, Kvaløy S, Giercksky KE, Skjeldal S (2010)
     Pain after palliative radiotherapy for spine metastases
     Clin Oncol (R Coll Radiol), 22 (10), 828-36
     PubMed 20363110

Publications 2009

1. Ahlner-Elmqvist M, Bjordal K, Jordhøy MS, Kaasa S, Jannert M (2009)
   Characteristics and implications of attrition in health-related quality of life studies in palliative care
   Palliat Med, 23 (5), 432-40
   PubMed 19304808
2. Akkök CA, Holte MR, Tangen JM, Ostenstad B, Bruserud O (2009)
   Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells
   Transfusion, 49 (2), 354-61
   PubMed 18980622
3. Aksnes LH, Bauer HC, Dahl AA, Fosså SD, Hjorth L, Jebsen N, Lernedal H, Hall KS (2009)
   Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: a Scandinavian sarcoma group study
   Pediatr Blood Cancer, 53 (1), 84-9
   PubMed 19343771
4. Andersen NS, Pedersen LB, Laurell A, Elonen E, Kolstad A, Boesen AM, Pedersen LM, Lauritzsen GF, Ekanger R, Nilsson-Ehle H, Nordström M, Fredén S, Jerkeman M, Eriksson M, Väärt J, Malmer B, Geisler CH (2009)
   Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma
   J Clin Oncol, 27 (26), 4365-70
   PubMed 19652064
5. Andersen V, Agerstjerne L, Jensen D, Østergaard M, Saebø M, Hamfjord J, Kure E, Vogel U (2009)
   The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study
   BMC Med Genet, 10, 18
   PubMed 19250544
6. Andersson Y, Engebraaten O, Fodstad Ø (2009)
   Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
   Br J Cancer, 101 (8), 1307-15
   PubMed 19773757
7. André B, Ringdal GI, Loge JH, Rannestad T, Kaasa S (2009)
   Implementation of computerized technology in a palliative care unit
   Palliat Support Care, 7 (1), 57-63
   PubMed 19619375
8. Arriagada R, Averbeck D, Dahl AA, Darby S, Fosså S, Friberg S, Polgár C, de Vathaire F (2009)
   OECI Workshop on late side-effects of cancer treatments
   Eur J Cancer, 45 (3), 354-9
   PubMed 19081244
9. Bassarova A, Trøen G, Fosså A, Ikonomou IM, Beiske K, Nesland JM, Delabie J (2009)
   Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation
   J Hematop, 2 (3), 135-41
   PubMed 19669194
10. Bauer HCF, Folleras G, Kivioja A, Rydholm A, von Steyern FV (2009)
    Giant cell tumor of bone The Scandinavian Sarcoma Group experience
    Acta Orthop., 80, 79-81
11. Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
    Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
    Prostate Cancer Prostatic Dis, 12 (3), 269-76
    PubMed 19290019
12. Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O (2009)
    Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
    Mol Oncol, 3 (5-6), 469-82
    PubMed 19713161
13. Bjelland I, Lie SA, Dahl AA, Mykletun A, Stordal E, Kraemer HC (2009)
    A dimensional versus a categorical approach to diagnosis: anxiety and depression in the HUNT 2 study
    Int J Methods Psychiatr Res, 18 (2), 128-37
    PubMed 19507162
14. Bjerner J, Biernat D, Fosså SD, Bjøro T (2009)
    Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
    Scand J Clin Lab Invest, 69 (8), 873-9.e1-11
    PubMed 19929279
15. Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB (2009)
    Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
    J Clin Oncol, 27 (25), 4116-23
    PubMed 19636016
16. Bouwhuis MG, Suciu S, Collette S, Aamdal S, Kruit WH, Bastholt L, Stierner U, Salès F, Patel P, Punt CJ, Hernberg M, Spatz A, ten Hagen TL, Hansson J, Eggermont AM, EORTC Melanoma Group and the Nordic Melanoma Group (2009)
    Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon
    J Natl Cancer Inst, 101 (12), 869-77
    PubMed 19509353
17. Bower WF, Vlantis AC, Chung TM, Cheung SK, Bjordal K, van Hasselt CA (2009)
    Quality of life in head and neck cancer patients after surgical resection: translation into Cantonese and validation of the EORTC QLQ-H&N35
    Acta Otolaryngol, 129 (7), 779-85
    PubMed 18767001
18. Brandal P, Bjerkehagen B, Bruland OS, Skjeldal S, Bogsrud TV, Hall KS (2009)
    Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience
    Acta Oncol, 48 (8), 1165-72
    PubMed 19863225
19. Brandal P, Panagopoulos I, Bjerkehagen B, Heim S (2009)
    t(19;22)(q13;q12) Translocation leading to the novel fusion gene EWSR1-ZNF444 in soft tissue myoepithelial carcinoma
    Genes Chromosomes Cancer, 48 (12), 1051-6
    PubMed 19760602
20. Bratland A, Boender PJ, Høifødt HK, Østensen IH, Ruijtenbeek R, Wang MY, Berg JP, Lilleby W, Fodstad Ø, Ree AH (2009)
    Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling
    Clin Exp Metastasis, 26 (5), 485-96
    PubMed 19294521
21. Brekke HR, Kolberg M, Skotheim RI, Hall KS, Bjerkehagen B, Risberg B, Domanski HA, Mandahl N, Liestøl K, Smeland S, Danielsen HE, Mertens F, Lothe RA (2009)
    Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
    Neuro Oncol, 11 (5), 514-28
    PubMed 19182148
22. Bruland ØS, Bauer H, Alvegaard T, Smeland S (2009)
    Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience
    Cancer Treat Res, 152, 309-18
    PubMed 20213398
23. Bruland ØS, Høifødt H, Hall KS, Smeland S, Fodstad Ø (2009)
    Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients
    Cancer Treat Res, 152, 509-15
    PubMed 20213412
24. Brydøy M, Oldenburg J, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Hauge ER, Dahl O, Fosså SD (2009)
    Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors
    J Natl Cancer Inst, 101 (24), 1682-95
    PubMed 19940282
25. Baatrup G, Endreseth BH, Isaksen V, Kjellmo A, Tveit KM, Nesbakken A (2009)
    Preoperative staging and treatment options in T1 rectal adenocarcinoma
    Acta Oncol, 48 (3), 328-42
    PubMed 19180365
26. Christoffersen T, Guren TK, Spindler KL, Dahl O, Lønning PE, Gjertsen BT (2009)
    Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues
    Eur J Pharmacol, 625 (1-3), 6-22
    PubMed 19836383
27. Cvancarova M, Samuelsen SO, Fossa SD (2009)
    Reproduction Rates After Cytotoxic Therapy Reply
    J. Clin. Oncol., 27 (27), E120
28. Cvancarova M, Samuelsen SO, Magelssen H, Fosså SD (2009)
    Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
    J Clin Oncol, 27 (3), 334-43
    PubMed 19075285
29. Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM, Norwegian Gastrointestinal Cancer Group (2009)
    Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group
    Acta Oncol, 48 (3), 368-76
    PubMed 19242829
30. Dahl AA, Krüger MB, Dahl NH, Karlsson H, Von Knorring L, Stordal E (2009)
    SPIFA-A presentation of the Structured Psychiatric Interview for General Practice
    Nord J Psychiatry, 63 (6), 443-53
    PubMed 19370449
31. Dahlback HS, Brandal P, Meling TR, Gorunova L, Scheie D, Heim S (2009)
    Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways
    Genes Chromosomes Cancer, 48 (10), 908-24
    PubMed 19603525
32. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
    Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
    Histol Histopathol, 24 (8), 1049-59
    PubMed 19554512
33. Dueland S, Aamdal S, Lind MJ, Thomas H, Sandvold ML, Gaullier JM, Rasch W (2009)
    Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study
    Acta Oncol, 48 (1), 137-45
    PubMed 18607882
34. Dybvik E, Furnes O, Fosså SD, Trovik C, Lie SA (2009)
    Long-term risk of receiving a total hip replacement in cancer patients
    Cancer Epidemiol, 33 (3-4), 235-41
    PubMed 19744907
35. Eide N, Faye RS, Høifødt HK, Øvergaard R, Jebsen P, Kvalheim G, Fodstad Ø (2009)
    Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients
    Acta Ophthalmol, 87 (8), 830-6
    PubMed 19055657
36. Elmqvist MA, Jordhøy MS, Bjordal K, Kaasa S, Jannert M (2009)
    Health-related quality of life during the last three months of life in patients with advanced cancer
    Support Care Cancer, 17 (2), 191-8
    PubMed 18581147
37. Evensen JF (2009)
    Kreft i hode og hals
    Medikamentell kreftbehandling ? Cytostatikaboken, 7, 451-459
    PublikaID 57
38. Finstad SE, Emaus A, Potischman N, Barrett E, Furberg AS, Ellison PT, Jasienska G, Thune I (2009)
    Influence of birth weight and adult body composition on 17beta-estradiol levels in young women
    Cancer Causes Control, 20 (2), 233-42
    PubMed 18853264
39. Finstad SE, Emaus A, Tretli S, Jasienska G, Ellison PT, Furberg AS, Wist EA, Thune I (2009)
    Adult height, insulin, and 17beta-estradiol in young women
    Cancer Epidemiol Biomarkers Prev, 18 (5), 1477-83
    PubMed 19423524
40. Fluge Ø, Gravdal K, Carlsen E, Vonen B, Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM, Otte AP, Akslen LA, Dahl O, Norwegian Gastrointestinal Cancer Group (2009)
    Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
    Br J Cancer, 101 (8), 1282-9
    PubMed 19773751
41. Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
    [Incorrect about hormone treatment in prostatic cancer]
    Tidsskr Nor Laegeforen, 129 (5), 429
    PubMed 19247406
42. Fosså SD, Oldenburg J, Dahl AA (2009)
    Short- and long-term morbidity after treatment for testicular cancer
    BJU Int, 104 (9 Pt B), 1418-22
    PubMed 19840023
43. Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A, Scandinavian Prostate Cancer Group Study 7, Swedish Association for Urological Oncology 3 (2009)
    Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial
    Lancet Oncol, 10 (4), 370-80
    PubMed 19286422
44. Fyllingen EH, Oldervoll LM, Loge JH, Hjermstad MJ, Haugen DF, Sigurdardottir KR, Paulsen O, Kaasa S, European Palliative Care Research Collaborative (2009)
    Computer-based assessment of symptoms and mobility in palliative care: feasibility and challenges
    J Pain Symptom Manage, 38 (6), 827-36
    PubMed 19833476
45. Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z (2009)
    Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3
    Ultrastruct Pathol, 33 (4), 175-81
    PubMed 19728235
46. Geisler C, Kolstad A, Laurell A, Räty R, Nordic Lymphoma Group, Mantle Cell Lymphoma Subcommittee (2009)
    Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?
    Leuk Lymphoma, 50 (8), 1249-56
    PubMed 19562619
47. Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S (2009)
    A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide
    Clin Cancer Res, 15 (12), 4165-73
    PubMed 19509150
48. Gorunova L, Vult von Steyern F, Storlazzi CT, Bjerkehagen B, Follerås G, Heim S, Mandahl N, Mertens F (2009)
    Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations
    Genes Chromosomes Cancer, 48 (7), 583-602
    PubMed 19396867
49. Grov EK, Fosså SD, Bremnes RM, Dahl O, Klepp O, Wist E, Dahl AA (2009)
    The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors
    Acta Oncol, 48 (6), 842-9
    PubMed 19412812
50. Grov EK, Fosså SD, Dahl AA (2009)
    Is somatic comorbidity associated with more somatic symptoms, mental distress, or unhealthy lifestyle in elderly cancer survivors?
    J Cancer Surviv, 3 (2), 109-16
    PubMed 19241174
51. Grønberg BH, Bremnes RM, Fløtten O, Amundsen T, Brunsvig PF, Hjelde HH, Kaasa S, von Plessen C, Stornes F, Tollåli T, Wammer F, Aasebø U, Sundstrøm S (2009)
    Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer
    J Clin Oncol, 27 (19), 3217-24
    PubMed 19433683
52. Grønberg BH, Bremnes RM, Aasebø U, Brunsvig P, Fløtten O, Amundsen T, von Plessen C, Wang M, Sundstrøm S, Norwegian Lung Cancer Study Group (2009)
    A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer
    Lung Cancer, 63 (1), 88-93
    PubMed 18538889
53. Grøndahl P, Vaerøy H, Dahl AA (2009)
    A study of amnesia in homicide cases and forensic psychiatric experts' examination of such claims
    Int J Law Psychiatry, 32 (5), 281-7
    PubMed 19665794
54. Gudbergsson SB, Dahl AA (2009)
    [How do cancer patients cope at work?]
    Tidsskr Nor Laegeforen, 129 (11), 1116-7
    PubMed 19488095
55. Gudbergsson SB, Fosså SD, Lindbohm ML, Dahl AA (2009)
    Received and needed social support at the workplace in Norwegian and Finnish stage 1 breast cancer survivors: a study from the Nordic Study Group of Cancer and Work (NOCWO)
    Acta Oncol, 48 (1), 67-75
    PubMed 18759139
56. Gunnes N, Seierstad TG, Aamdal S, Brunsvig PF, Jacobsen AB, Sundstrøm S, Aalen OO (2009)
    Assessing quality of life in a randomized clinical trial: correcting for missing data
    BMC Med Res Methodol, 9, 28
    PubMed 19405936
57. Hall KS, Eriksson M, Bruland OS, Engellau J, Trovik CS (2009)
    Treatment of soft tissue sarcoma of the extremity and trunk wall The Scandinavian Sarcoma Group perspective
    Acta Orthop., 80, 52-59
58. Hansen MH, Balteskard L, Dørum LM, Eriksen MT, Vonen B, Norwegian Colorectal Cancer Group (2009)
    Locally recurrent rectal cancer in Norway
    Br J Surg, 96 (10), 1176-82
    PubMed 19787766
59. Hansteen IL, Lågeide L, Clausen KO, Haugan V, Svendsen M, Eriksen JG, Skiaker R, Hauger E, Vistnes AI, Kure EH (2009)
    Cytogenetic effects of 18.0 and 16.5 GHz microwave radiation on human lymphocytes in vitro
    Anticancer Res, 29 (8), 2885-92
    PubMed 19661291
60. Haugnes HS, Aass N, Fosså SD, Dahl O, Brydøy M, Aasebø U, Wilsgaard T, Bremnes RM (2009)
    Pulmonary function in long-term survivors of testicular cancer
    J Clin Oncol, 27 (17), 2779-86
    PubMed 19414680
61. Helbostad JL, Hølen JC, Jordhøy MS, Ringdal GI, Oldervoll L, Kaasa S, European Association for Palliative Care (EAPC) Research Network (2009)
    A first step in the development of an international self-report instrument for physical functioning in palliative cancer care: a systematic literature review and an expert opinion evaluation study
    J Pain Symptom Manage, 37 (2), 196-205
    PubMed 18619767
62. Helland A, Brustugun OT (2009)
    [Lung cancer in smokers and never-smokers]
    Tidsskr Nor Laegeforen, 129 (18), 1859-62
    PubMed 19844277
63. Hildrum B, Mykletun A, Dahl AA, Midthjell K (2009)
    Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT)
    Diabetologia, 52 (4), 583-90
    PubMed 19194692
64. Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA (2009)
    No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study
    Acta Psychiatr Scand, 120 (1), 14-22
    PubMed 19120047
65. Hjermstad MJ, Fainsinger R, Kaasa S, European Palliative Care Research Collaborative (EPCRC) (2009)
    Assessment and classification of cancer pain
    Curr Opin Support Palliat Care, 3 (1), 24-30
    PubMed 19365158
66. Holte H, Kvaløy S, Delabie J, Trøen G, Smeland EB (2009)
    [Molecular diagnosis of malignant lymphomas]
    Tidsskr Nor Laegeforen, 129 (22), 2352-6
    PubMed 19935935
67. Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R (2009)
    Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
    Blood, 114 (16), 3431-8
    PubMed 19641184
68. Huang TS, Grodeland G, Sleire L, Wang MY, Kvalheim G, Laerum OD (2009)
    Induction of circadian rhythm in cultured human mesenchymal stem cells by serum shock and cAMP analogs in vitro
    Chronobiol Int, 26 (2), 242-57
    PubMed 19212839
69. Jetne V, Kvaløy S, Smeland S, Johannesen TB, Tveit KM (2009)
    [Use of radiotherapy in South-Eastern Norway Regional Health Authority]
    Tidsskr Nor Laegeforen, 129 (24), 2602-5
    PubMed 20029555
70. Kalager M, Kåresen R, Wist E (2009)
    [Survival after breast cancer--differences between Norwegian counties]
    Tidsskr Nor Laegeforen, 129 (24), 2595-600
    PubMed 20029554
71. Kamalakaran S, Kendall J, Zhao X, Tang C, Khan S, Ravi K, Auletta T, Riggs M, Wang Y, Helland A, Naume B, Dimitrova N, Børresen-Dale AL, Hicks J, Lucito R (2009)
    Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation
    Nucleic Acids Res, 37 (12), e89
    PubMed 19474344
72. Kelly JL, Toothaker SR, Ciminello L, Hoelzer D, Holte H, LaCasce AS, Mead G, Thomas D, Van Imhoff GW, Kahl BS, Cheson BD, Magrath IT, Fisher RI, Friedberg JW (2009)
    Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens
    Clin Lymphoma Myeloma, 9 (4), 307-10
    PubMed 19717381
73. Kiserud CE, Fosså A, Bjøro T, Holte H, Cvancarova M, Fosså SD (2009)
    Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
    Br J Cancer, 100 (3), 455-63
    PubMed 19156143
74. Kiserud CE, Schover LR, Dahl AA, Fosså A, Bjøro T, Loge JH, Holte H, Yuan Y, Fosså SD (2009)
    Do male lymphoma survivors have impaired sexual function?
    J Clin Oncol, 27 (35), 6019-26
    PubMed 19858388
75. Kjaergaard T, Cvancarova M, Steinsvåg SK (2009)
    Relation of nasal air flow to nasal cavity dimensions
    Arch Otolaryngol Head Neck Surg, 135 (6), 565-70
    PubMed 19528404
76. Kjaergaard T, Cvancarova M, Steinsvåg SK (2009)
    Nasal congestion index: A measure for nasal obstruction
    Laryngoscope, 119 (8), 1628-32
    PubMed 19507219
77. Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y et al. (2009)
    TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
    Lancet Oncol, 10 (8), 772-84
    PubMed 19625214
78. Knudsen AK, Aass N, Fainsinger R, Caraceni A, Klepstad P, Jordhøy M, Hjermstad MJ, Kaasa S (2009)
    Classification of pain in cancer patients--a systematic literature review
    Palliat Med, 23 (4), 295-308
    PubMed 19286741
79. Kraggerud SM, Oldenburg J, Alnaes GI, Berg M, Kristensen VN, Fossa SD, Lothe RA (2009)
    Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology
    Pharmacogenet Genomics, 19 (10), 751-9
    PubMed 19741569
80. Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
    Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
    Eur J Haematol, 83 (4), 279-89
    PubMed 19558508
81. Kvåle R, Møller B, Wahlqvist R, Fosså SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ (2009)
    Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
    BJU Int, 103 (12), 1647-54
    PubMed 19154461
82. Kyte JA (2009)
    Cancer vaccination with telomerase peptide GV1001
    Expert Opin Investig Drugs, 18 (5), 687-94
    PubMed 19388882
83. Kyte JA, Trachsel S, Risberg B, thor Straten P, Lislerud K, Gaudernack G (2009)
    Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
    Cancer Immunol Immunother, 58 (10), 1609-26
    PubMed 19221745
84. Landmark-Høyvik H, Reinertsen KV, Loge JH, Fosså SD, Børresen-Dale AL, Dumeaux V (2009)
    Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors
    Pharmacogenomics J, 9 (5), 333-40
    PubMed 19546881
85. Larsen SG, Wiig JN, Emblemsvaag HL, Grøholt KK, Hole KH, Bentsen A, Dueland S, Vetrhus T, Giercksky KE (2009)
    Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging
    Colorectal Dis, 11 (7), 759-67
    PubMed 18662240
86. Lehne G, Grasmo-Wendler UH, Berner JM, Meza-Zepeda LA, Adamsen BL, Flack A, Reiner A, Clausen OP, Hovig E, Myklebost O (2009)
    Upregulation of stem cell genes in multidrug resistant K562 leukemia cells
    Leuk Res, 33 (10), 1379-85
    PubMed 19394083
87. Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS (2009)
    Small round cell sarcomas
    Semin Oncol, 36 (4), 338-46
    PubMed 19664494
88. Liavaag AH, Dørum A, Fosså SD, Tropé C, Dahl AA (2009)
    Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors
    BMC Cancer, 9, 2
    PubMed 19121203
89. Mai PL, Chen BE, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E, Heimdal K, Fosså SD, Nathanson KL, Korde L, Easton DF, Dudakia D, Huddart R, Stratton MR, Bishop DT, Rapley EA, Greene MH (2009)
    Younger age-at-diagnosis for familial malignant testicular germ cell tumor
    Fam Cancer, 8 (4), 451-6
    PubMed 19609727
90. Marina N, Bielack S, Whelan J, Smeland S, Krailo M, Sydes MR, Butterfass-Bahloul T, Calaminus G, Bernstein M (2009)
    International collaboration is feasible in trials for rare conditions: the EURAMOS experience
    Cancer Treat Res, 152, 339-53
    PubMed 20213400
91. Michelsen TM, Dørum A, Dahl AA (2009)
    A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer
    Gynecol Oncol, 113 (1), 128-33
    PubMed 19178933
92. Michelsen TM, Dørum A, Tropé CG, Fosså SD, Dahl AA (2009)
    Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer
    Int J Gynecol Cancer, 19 (6), 1029-36
    PubMed 19820364
93. Murph MM, Liu W, Yu S, Lu Y, Hall H, Hennessy BT, Lahad J, Schaner M, Helland A, Kristensen G, Børresen-Dale AL, Mills GB (2009)
    Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis
    PLoS One, 4 (5), e5583
    PubMed 19440550
94. Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B, Iversen PO (2009)
    Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
    Leukemia, 23 (1), 162-9
    PubMed 18800145
95. Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Østenstad B, Sandset PM, Iversen PO (2009)
    Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas
    Leuk Lymphoma, 50 (6), 998-1004
    PubMed 19373600
96. Nesvold IL, Fosså SD, Naume B, Dahl AA (2009)
    Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors
    Breast Cancer Res Treat, 117 (2), 281-8
    PubMed 19112616
97. Nieder C, Pawinski A, Balteskard L (2009)
    Colorectal cancer metastatic to the brain: time trends in presentation and outcome
    Oncology, 76 (5), 369-74
    PubMed 19321946
98. Norum OJ, Bruland ØS, Gorunova L, Berg K (2009)
    Photochemical internalization of bleomycin before external-beam radiotherapy improves locoregional control in a human sarcoma model
    Int J Radiat Oncol Biol Phys, 75 (3), 878-85
    PubMed 19665318
99. O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, Wrench D, Gribben J, Rosenwald A, Ott G, Rimsza LM, Holte H, Cazier JB, Johnson NA, Campo E, Chan WC, Gascoyne RD, Young BD, Staudt LM, Lister TA, Fitzgibbon J (2009)
    Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation
    Blood, 113 (10), 2298-301
    PubMed 19141865
100. Oldenburg J, Fosså SD (2009)
     Late relapse of nonseminomatous germ cell tumours
     BJU Int, 104 (9 Pt B), 1413-7
     PubMed 19840022
101. Oldenburg J, Fosså SD (2009)
     [Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders]
     Urologe A, 48 (4), 372-6
     PubMed 19234684
102. Oldenburg J, Fosså SD (2009)
     Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations
     Acta Oncol, 48 (6), 804-6
     PubMed 19484592
103. Oldenburg J, Wahlqvist R, Fosså SD (2009)
     Late relapse of germ cell tumors
     World J Urol, 27 (4), 493-500
     PubMed 19373473
104. Olssøn I, Dahl AA (2009)
     Personality problems are considerably associated with somatic morbidity and health care utilisation
     Eur Psychiatry, 24 (7), 442-9
     PubMed 19540726
105. Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009)
     Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
     Brain Behav Immun, 23 (6), 868-74
     PubMed 19362138
106. Paltiel H, Solvoll E, Loge JH, Kaasa S, Oldervoll L (2009)
     "The healthy me appears": palliative cancer patients' experiences of participation in a physical group exercise program
     Palliat Support Care, 7 (4), 459-67
     PubMed 19939308
107. Park D, Kåresen R, Naume B, Synnestvedt M, Beraki E, Sauer T (2009)
     The prognostic impact of occult nodal metastasis in early breast carcinoma
     Breast Cancer Res Treat, 118 (1), 57-66
     PubMed 19219629
108. Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group (2009)
     Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
     Radiother Oncol, 92 (1), 4-14
     PubMed 19446902
109. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A, EORTC Clinical Groups (2009)
     Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
     Lancet Oncol, 10 (9), 865-71
     PubMed 19695956
110. Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, Fosså SD (2009)
     Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
     Int J Radiat Oncol Biol Phys, 75 (3), 764-70
     PubMed 19286332
111. Rennemo E, Zätterström U, Evensen J, Boysen M (2009)
     Reduced risk of head and neck second primary tumors after radiotherapy
     Radiother Oncol, 93 (3), 559-62
     PubMed 19747745
112. Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
     Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
     Anticancer Res, 29 (11), 4331-6
     PubMed 20032375
113. Rogg L, Loge JH, Aasland OG, Graugaard PK (2009)
     Physicians' attitudes towards disclosure of prognostic information: a survey among a representative cross-section of 1605 Norwegian physicians
     Patient Educ Couns, 77 (2), 242-7
     PubMed 19356882
114. Rud AK, Bjørgo S, Kristensen GB, Kongsgaard UE (2009)
     Hyperbaric oxygen therapy for late radiation tissue injury in gynaecological patients
     Support Care Cancer, 17 (12), 1517-21
     PubMed 19319575
115. Sagerup CM, Brustugun OT, Jørgensen L (2009)
     [A 67-year old man with right arm paresthesias]
     Tidsskr Nor Laegeforen, 129 (24), 2613-5
     PubMed 20029558
116. Sakhi AK, Russnes KM, Thoresen M, Bastani NE, Karlsen A, Smeland S, Blomhoff R (2009)
     Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study
     BMC Cancer, 9, 458
     PubMed 20025747
117. Sande TA, Ruenes R, Lund JA, Bruland OS, Hornslien K, Bremnes R, Kaasa S (2009)
     Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial
     Radiother Oncol, 91 (2), 261-6
     PubMed 19307034
118. Schröder FH, Kurth KH, Fossa SD, Hoekstra W, Karthaus PP, De Prijck L, Collette L (2009)
     Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial)
     Eur Urol, 55 (1), 14-22
     PubMed 18823693
119. Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S (2009)
     The role of radiotherapy in oseosarcoma
     Cancer Treat Res, 152, 147-64
     PubMed 20213389
120. Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, Tveit KM, Kure EH, Vogel U, Vogel LK (2009)
     Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis
     BMC Cancer, 9, 201
     PubMed 19555470
121. Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH (2009)
     Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema
     Acta Radiol, 50 (6), 682-9
     PubMed 19449234
122. Skovbjerg H, Anthonsen D, Lothe IM, Tveit KM, Kure EH, Vogel LK (2009)
     Collagen mRNA levels changes during colorectal cancer carcinogenesis
     BMC Cancer, 9, 136
     PubMed 19422682
123. Skaali T, Fosså SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, Klepp O, Oldenburg J, Wist E, Dahl AA (2009)
     Fear of recurrence in long-term testicular cancer survivors
     Psychooncology, 18 (6), 580-8
     PubMed 18855944
124. Smeland S, Bruland OS, Hjorth L, Brosjo O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Bjork O, Alvegaard TA (2009)
     Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
     Acta Orthop., 80, 60-66
125. Smeland S, Wiebe T, Monge OR, Brosjo O, Bohling T, Hjorth L, Hall KS, Jakobson A, Alvegaard TA (2009)
     Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
     Acta Orthop., 80, 75-78
126. Sommer OH, Aga O, Cvancarova M, Olsen IC, Selbaek G, Engedal K (2009)
     Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia
     Dement Geriatr Cogn Disord, 27 (2), 155-63
     PubMed 19182483
127. Stensheim H, Miller B, van Dijk T, Fossa SD (2009)
     Cancer During Pregnancy: The Time Has Come for a Prospective Program Reply
     J. Clin. Oncol., 27 (13), 2299
128. Stensheim H, Moller B, van Dijk T, Fossa SD (2009)
     Cutaneous Melanoma During Pregnancy: Is the Controversy Over? Reply
     J. Clin. Oncol., 27 (19), E13-E14
129. Stensheim H, Møller B, van Dijk T, Fosså SD (2009)
     Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study
     J Clin Oncol, 27 (1), 45-51
     PubMed 19029418
130. Svindseth MF, Sørebø O, Nøttestad JA, Roaldset JO, Wallin J, Dahl AA (2009)
     Psychometric examination and normative data for the narcissistic personality inventory 29 item version
     Scand J Psychol, 50 (2), 151-9
     PubMed 18826419
131. Søvik S, Skogmo HK, Andersen EK, Bruland ØS, Olsen DR, Malinen E (2009)
     DCEMRI of spontaneous canine tumors during fractionated radiotherapy: a pharmacokinetic analysis
     Radiother Oncol, 93 (3), 618-24
     PubMed 19747746
132. Tandstad T, Dahl O, Cohn-Cedermark G, Cavallin-Stahl E, Stierner U, Solberg A, Langberg C, Bremnes RM, Laurell A, Wijkstrøm H, Klepp O (2009)
     Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program
     J Clin Oncol, 27 (13), 2122-8
     PubMed 19307506
133. Utne I, Miaskowski C, Bjordal K, Cooper BA, Valeberg BT, Rustøen T (2009)
     Confirmatory factor analysis of the coping strategies questionnaire-revised in samples of oncology outpatients and inpatients with pain
     Clin J Pain, 25 (5), 391-400
     PubMed 19454872
134. Utne I, Miaskowski C, Bjordal K, Paul SM, Jakobsen G, Rustøen T (2009)